Видео с ютуба Sorafenib

What is sorafenib?

Sorafenib Side Effect Management in Thyroid Cancer

BTTC Everolimus/Sorafenib Study Rationale

SIRT Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (SIRveNIB Study)

Managing Toxicities with Sorafenib in HCC

Inhibiting DKK1 enhances sorafenib efficacy in HCC

Dr. Kasper on Imatinib Versus Sorafenib in Sarcoma

Dosing Strategies With Sorafenib in HCC

Sorafenib Initiation After TACE in HCC

HCC: Considerations in First-Line Use of Sorafenib

Regorafenib Vs Sorafenib in the Treatment of Liver Cancer

Сорафениб и ваши гены

Dr. El-Khoueiry on Choosing Between Lenvatinib and Sorafenib in HCC

Results from a Phase III study of sorafenib and SBRT for hepatocellular carcinoma

Dr. Brose Discusses The Tolerability of Sorafenib in Thyroid Cancer

Rationale and study design of a Phase III study of sorafenib and SBRT for hepatocellular carcinoma

Sorafenib in Advanced DTC

Oncotarget: Evaluating the Role of IGF/CTP Composite Score in Sorafenib Treatment

Assessing Response to Sorafenib

Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers